Summary

Location
at San Francisco, California and other locations
Dates
study started
completion around

Description

Summary

Official Title

Gaucher Disease Registry Protocol

Keywords

Gaucher Disease, Cerebroside Lipidosis Syndrome, Glucocerebrosidase Deficiency Disease, Glucosylceramide Beta-Glucosidase Deficiency Disease, Lipidoses, Deficiency Diseases

Eligibility

Locations

  • University of California at San Francisco- Site Number : 840051 accepting new patients
    San Francisco California United States
  • Stanford Unviersity MC Dept of Genetics- Site Number : 840022 accepting new patients
    Palo Alto California 94305 United States

Details

Status
accepting new patients
Start Date
Completion Date
(estimated)
Sponsor
Genzyme, a Sanofi Company
ID
NCT00358943
Study Type
Observational [Patient Registry]
Participants
Expecting 12000 study participants
Last Updated